| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.072 | 0.2 |